PlainRecalls
FDA Drug Moderate Class II Ongoing

Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3

Reported: November 27, 2024 Initiated: October 31, 2024 #D-0055-2025

Product Description

Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3

Reason for Recall

Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).

Details

Recalling Firm
Noven Pharmaceuticals Inc
Units Affected
685 boxes
Distribution
USA nationwide.
Location
Miami, FL

Frequently Asked Questions

What product was recalled?
Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3. Recalled by Noven Pharmaceuticals Inc. Units affected: 685 boxes.
Why was this product recalled?
Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).
Which agency issued this recall?
This recall was issued by the FDA Drug on November 27, 2024. Severity: Moderate. Recall number: D-0055-2025.